AK119, A CD73 TARGETING ANTIBODY WITH DUAL MECHANISM OF ACTION

被引：1

作者：

Huang, Zhaoliang ^{[1
]}

Pang, Xinghua ^{[2
]}

Zhong, Tingting ^{[2
]}

Jin, Chunshan ^{[2
]}

Chen, Na ^{[2
]}

He, Xinrong ^{[2
]}

Xia, Dennis ^{[2
]}

Jin, Xiaoping ^{[3
]}

Wang, Zhongmin ^{[2
]}

Xia, Xu ^{[2
]}

Li, Baiyong ^{[2
]}

机构：

[1] Akeso Bliopharma Inc, Zhongshan, Peoples R China

[2] Akeso Biopharma Inc, Zhongshan, Peoples R China

[3] Akeso Biopharma Inc, Potomac, MD USA

来源：

JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷

关键词：

D O I：

10.1136/jitc-2021-SITC2021.750

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

750

引用

页码：A783 / A784

页数：2

共 50 条

[21] A Novel Antagonistic CD73 Antibody for Inhibition of the Immunosuppressive Adenosine Pathway
Wurm, Melanie
Schaaf, Otmar
Reutner, Katharina
Ganesan, Rajkumar
Mostboeck, Sven
Pelster, Christina
Boettcher, Jark
Pereira, Bruna de Andrade
Taubert, Christina
Alt, Isabella
Serna, Garazi
Auguste, Aurelie
Stadermann, Kai B.
Delic, Denis
Han, Fei
Capdevila, Jaume
Nuciforo, Paolo G.
Kroe-Barrett, Rachel
Adam, Paul J.
Vogt, Anne B.
Hofmann, Irmgard
MOLECULAR CANCER THERAPEUTICS, 2021, 20 (11) : 2250 - 2261
[22] Discovery of Small and Bifunctional Molecules Targeting PD-L1/CD73 for Cancer Dual Immunotherapy
Wang, Shuanghu
Kong, Zhihua
Shi, Yaru
Shao, Chuxiao
Wang, Wei
Su, Zhenhong
Liu, Jin
Zhou, Yingxing
Fei, Xiaoting
Cheng, Binbin
Chen, Jianjun
Lu, Yiyu
Xiao, Jian
JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (11) : 9447 - 9464
[23] A highly potent CD73 biparatopic antibody blocks organization of the enzyme active site through dual mechanisms
Stefano, James E.
Lord, Dana M.
Zhou, Yanfeng
Jaworski, Julie
Hopke, Joern
Travaline, Tara
Zhang, Ningning
Wong, Karen
Lennon, Amanda
He, Timothy
Bric-Furlong, Eva
Cherrie, Cornishia
Magnay, Tristan
Remy, Elisabeth
Brondyk, William
Qiu, Huawei
Radosevic, Katarina
JOURNAL OF BIOLOGICAL CHEMISTRY, 2020, 295 (52) : 18379 - 18389
[24] A differentiated CD73 blocking antibody with a unique intra-dimer binding mechanism for cancer immunotherapy.
Wang, Zhengyi
Cao, Wei
Zhang, Yanni
Xu, Cong
Meng, Yuan
Guo, Taylor B.
CANCER RESEARCH, 2021, 81 (13)
[25] Identification of a murine monoclonal antibody specific for human CD73 and inhibiting extracellular adenosine production generated by the CD38/CD203a/CD73 ectoenzymatic pathway
Chillemi, Antonella
Horenstein, Alberto L.
Quarona, Valeria
Morandi, Fabio
Zaccarello, Gianluca
Zito, Andrea
Mariani, Valentina
Pistoia, Vito
Malavasi, Fabio
PURINERGIC SIGNALLING, 2014, 10 (04) : 825 - 826
[26] Targeting Metabolism of Extracellular Nucleotides via Inhibition of Ectonucleotidases CD73 and CD39
Jeffrey, Jenna L.
Lawson, Kenneth, V
Powers, Jay P.
JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (22) : 13444 - 13465
[27] Targeting the Immunomodulatory CD73/Adenosine System to Improve the Therapeutic Gain of Radiotherapy
de Leve, Simone
Wirsdoerfer, Florian
Jendrossek, Verena
FRONTIERS IN IMMUNOLOGY, 2019, 10
[28] Bispecific antibody CD73xEGFR more selectively inhibits the CD73/adenosine immune checkpoint on cancer cells and concurrently counteracts pro-oncogenic activities of CD73 and EGFR
Ploeg, Emily Maria
Samplonius, Douwe Freerk
Xiong, Xiao
Ke, Xiurong
Hendriks, Mark Alexander Johannes Martinus
Britsch, Isabel
van Wijngaarden, Anne Paulien
Zhang, Hao
Helfrich, Wijnand
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2023, 11 (09)
[29] Dual immunostimulatory CD73 antibody-polymeric cytotoxic drug complex for triple negative breast cancer therapy
Xie, Xiao
Yang, Ming
Wei, Xue
Chu, Hongyu
Zhao, Weidong
Shen, Na
ACTA BIOMATERIALIA, 2024, 189 : 532 - 544
[30] Efficacy of Combined Therapy with Near-Infrared Photoimmunotherapy Targeting CD73 and AntiPD-1 Antibody in Lung Cancer
Chiba, Ryohei
Nakajima, Kohei
Hatanaka, Kanako C.
Ujiie, Hideki
Aragaki, Masato
Kobayashi, Takuma
Konishi, Teppei
Hatanaka, Yutaka
Kato, Tatsuya
Ogawa, Mikako
CANCER SCIENCE, 2025, 116 : 534 - 534

← 1 2 3 4 5 →